Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic stem cell processing and cryopreservation.

S D Rowley1

  • 1Clinical Cryobiology Laboratory, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.

Journal of Clinical Apheresis
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.

Bone marrow transplantation·2016
Same author

Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.

Leukemia·2011
Same author

Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation.

Bone marrow transplantation·2011
Same author

Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade.

Cytotherapy·2010
Same author

A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch.

Bone marrow transplantation·2003
Same author

Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy.

Bone marrow transplantation·2003
Same journal

Calcium and Other Electrolyte Management in Patients Undergoing Leukocytapheresis Collections: Review and Recommendations From the American Society for Apheresis Clinical Applications Committee.

Journal of clinical apheresis·2026
Same journal

The Role of Therapeutic Apheresis in the Management of Rheumatoid Arthritis A Systematic Review and Meta-Analysis.

Journal of clinical apheresis·2026
Same journal

Thrombocytapheresis as a Bridge Intervention in JAK2-Mutant Myeloproliferative Neoplasm Complicated by Acquired von Willebrand Disease: A Case Report.

Journal of clinical apheresis·2026
Same journal

Plerixafor Plus G-CSF Versus Etoposide Combined With Cyclophosphamide and G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Single Center Observational Propensity Score-Matched Cohort Study.

Journal of clinical apheresis·2026
Same journal

Beyond the Centrifuge: Is FcRn Inhibition Ready to Replace Apheresis in Treatment of Guillain-Barré Syndrome?

Journal of clinical apheresis·2026
Same journal

Correction to "Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis System".

Journal of clinical apheresis·2026
See all related articles

Hematopoietic stem cell (HSC) transplantation involves processing harvested cells to enrich HSCs. Processing removes mature blood cells, improving cryopreservation and enabling effective tumor cell purging for better patient outcomes.

Area of Science:

  • Hematology
  • Transplant Immunology
  • Cellular Therapy

Background:

  • Autologous transplantation relies on hematopoietic stem cells (HSCs) from bone marrow or peripheral blood.
  • Harvested stem cell products are heterogeneous, with HSCs comprising a small fraction.
  • Processing is crucial for cryopreservation, toxicity reduction, and tumor cell purging.

Purpose of the Study:

  • To outline the necessity and methods for processing hematopoietic stem cell products.
  • To highlight challenges in standardizing tumor cell purging techniques.

Main Methods:

  • Harvesting HSCs from bone marrow or peripheral blood.
  • Processing includes volume reduction, cell depletion (mature blood cells, tumor cells), and cryopreservation.
  • Utilizing apheresis devices and cell washers for HSC enrichment.

Related Experiment Videos

Main Results:

  • Processing minimizes HSC loss while optimizing the product for engraftment.
  • Depletion of mature blood cells is essential for cryopreservation and toxicity avoidance.
  • Current tumor cell purging techniques lack standardization across transplant centers.

Conclusions:

  • Effective processing of hematopoietic stem cell products is vital for successful autologous transplantation.
  • Standardization of tumor cell purging methods is needed to improve transplant efficacy and patient safety.